AAOS 2022: Buccally Absorbed Cannabidiol for Pain After Arthroscopic Rotator Cuff Repair .
Buccally Absorbed Cannabidiol Shows Promise in Treating Pain and Improving Satisfaction Immediately Following Arthroscopic Rotator Cuff Repair: A Placebo-Controlled, DoubleBlinded, Randomized Trial
100 patients undergoing arthroscopic rotator cuff repair were randomized to receive 14 days of oral, buccally absorbed cannabidiol (CBD; 25mg [<80kg] or 50mg [>80kg], three times per day) or placebo. Outcomes of interest included Visual Analog Scale (VAS) for pain, opioid consumption, satisfaction with pain control, liver function, and nausea, assessed up to 14 days follow up. Cannabidiol result in signficantly lower VAS pain scores in the first day post-operation and greater patient satisfaction in the first 2 days post-operation vs. placebo. This benefit was more pronounced in the higher dose CBD group, which exceeded the minimal clinically important difference for VAS pain in shoulder arthroscopy. NO differences in opioid consumption or liver function were observed.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
